Skip to main content
Fig. 1 | BMC Neuroscience

Fig. 1

From: Exercise combined with postbiotics treatment results in synergistic improvement of mitochondrial function in the brain of male transgenic mice for Alzheimer’s disease

Fig. 1

Postbiotics inhibited Cu2+ and Zn2+ induced aggregation of Aβ-40. The disaggregation assay began with incubation of Aβ-40 (40 µM) with metal ions ([Cu2+] = 25 µM; [Zn2+] = 25 µM) at 37 °C for 1 day with gentle shaking, then appropriate postbiotics were added at the above doses: ([FRAMELIM®] = 10 and 100 µg/ml; [Bifidobacterium longum lys.] = 10 µg/ml; [Lactobacillus acidophilus lys.] = 10 µg/ml). After 1 day of further agitation, both UV/Vis spectral analysis and ThT fluorescence assay was performed. A FRAMELIM® inhibited Zn2+-induced aggregation only at dose of 100 µg/ml, whereas B Cu2+ induced increase in ThT fluorescence was much smaller compared to the effects of Zn2+ ions indicating limited aggregation. Cu2+ enhanced β-sheet aggregation was only slightly altered by FRAMELIM®. C FRAMELIM® at both dosages basically modulated the absorption pattern of Zn2+-induced Aβ-40 aggregates. D For Cu2+-induced Aβ-40 aggregation a minor modulation in the absorbance in the range of 190–200 nm by FRAMELIM® is observed. E Bifidobacterium longum lys. and Lactobacillus acidophilus lys. strongly reduced aggregations at dose of 10 µg/ml in the presence of Zn2+ ions. F Similar results were observed in the case of Cu2+ ions: both postbiotics were very effective in inhibition. G Both postbiotics basically modulated absorbance pattern of Zn2+-induced Aβ-40 aggregates. H For Cu2+-induced Aβ-40 aggregation, a slight modulation of absorption in the 190–200 nm range by postbiotics is observed, similar to FRAMELIM®

Back to article page